Patients with cT1-2 N0 oral tongue squamous cell carcinomas with known > 3-mm DOI should be counseled on the possible survival benefit of END with primary tumor resection.
![](https://www.enttoday.org/wp-content/uploads/2016/09/ENT_0916_pg6a-150x150.png)
Patients with cT1-2 N0 oral tongue squamous cell carcinomas with known > 3-mm DOI should be counseled on the possible survival benefit of END with primary tumor resection.
The only treatments that have been clearly shown to be effective are antibiotics for wet CC and inhaled steroids for dry CC
The decision to proceed with elective neck dissection (END) is based on the probability of finding microscopic disease in a patient without clinical evidence of lymph node metastases
SLNB has emerged as a powerful adjunct to END in early-stage OSCC to identify cervical metastases
The push technique for PEG placement is associated with a lower incidence of PEG-site metastases when compared to the pull technique
Tympanomastoid surgery can be safely performed as an outpatient procedure in the pediatric population.
There is a growing body of evidence supporting the equivalence of endoscopic and open surgical approaches in terms of tumor recurrence
Recent myocardial infarction is known to be a significant risk factor for postoperative complications following elective, noncardiac surgery
Prophylaxis is administered to high-risk and offered to moderate-risk patients
Hyperbaric oxygen therapy continues to be employed for treatment of all stages of ORN despite its lack of proven efficacy